<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE90CA04-1D62-4D88-B6C3-6C30EC90B31E"><gtr:id>AE90CA04-1D62-4D88-B6C3-6C30EC90B31E</gtr:id><gtr:name>VU University Medical Center</gtr:name><gtr:address><gtr:line1>VU University Medical Center</gtr:line1><gtr:line2>vd Boechorststraat 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F959BC30-ED7F-4BE0-86D4-12BF9DEDC07E"><gtr:id>F959BC30-ED7F-4BE0-86D4-12BF9DEDC07E</gtr:id><gtr:name>University of Minho</gtr:name><gtr:address><gtr:line1>Gualtar Campus</gtr:line1><gtr:line2>4710 - 057 Braga</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Portugal</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A4BD8E9B-D382-420A-8ABD-F84D93965CD6"><gtr:id>A4BD8E9B-D382-420A-8ABD-F84D93965CD6</gtr:id><gtr:name>National Institute of Immunology India</gtr:name><gtr:address><gtr:line1>Aruna Asaf Ali Marg</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D0E5523-4FD8-4118-96AB-9734BBA04983"><gtr:id>1D0E5523-4FD8-4118-96AB-9734BBA04983</gtr:id><gtr:name>Osaka City University</gtr:name><gtr:address><gtr:line1>Osaka City University</gtr:line1><gtr:line2>3-3-138 Sugimoto</gtr:line2><gtr:line3>Sumiyoshi-Ku</gtr:line3><gtr:postCode>558-8585</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9AB78999-CAB7-401A-B3A4-0068465A9D2F"><gtr:id>9AB78999-CAB7-401A-B3A4-0068465A9D2F</gtr:id><gtr:name>Indian Institute of Science Bangalore</gtr:name><gtr:address><gtr:line1>2nd Floor, CAOS Building</gtr:line1><gtr:postCode>560 012</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>India</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Sch of Biosciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE90CA04-1D62-4D88-B6C3-6C30EC90B31E"><gtr:id>AE90CA04-1D62-4D88-B6C3-6C30EC90B31E</gtr:id><gtr:name>VU University Medical Center</gtr:name><gtr:address><gtr:line1>VU University Medical Center</gtr:line1><gtr:line2>vd Boechorststraat 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F959BC30-ED7F-4BE0-86D4-12BF9DEDC07E"><gtr:id>F959BC30-ED7F-4BE0-86D4-12BF9DEDC07E</gtr:id><gtr:name>University of Minho</gtr:name><gtr:address><gtr:line1>Gualtar Campus</gtr:line1><gtr:line2>4710 - 057 Braga</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Portugal</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A4BD8E9B-D382-420A-8ABD-F84D93965CD6"><gtr:id>A4BD8E9B-D382-420A-8ABD-F84D93965CD6</gtr:id><gtr:name>National Institute of Immunology India</gtr:name><gtr:address><gtr:line1>Aruna Asaf Ali Marg</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D0E5523-4FD8-4118-96AB-9734BBA04983"><gtr:id>1D0E5523-4FD8-4118-96AB-9734BBA04983</gtr:id><gtr:name>Osaka City University</gtr:name><gtr:address><gtr:line1>Osaka City University</gtr:line1><gtr:line2>3-3-138 Sugimoto</gtr:line2><gtr:line3>Sumiyoshi-Ku</gtr:line3><gtr:postCode>558-8585</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9AB78999-CAB7-401A-B3A4-0068465A9D2F"><gtr:id>9AB78999-CAB7-401A-B3A4-0068465A9D2F</gtr:id><gtr:name>Indian Institute of Science Bangalore</gtr:name><gtr:address><gtr:line1>2nd Floor, CAOS Building</gtr:line1><gtr:postCode>560 012</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>India</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9B873959-F552-4966-AEA7-FF3F211B5FEB"><gtr:id>9B873959-F552-4966-AEA7-FF3F211B5FEB</gtr:id><gtr:firstName>Apoorva</gtr:firstName><gtr:surname>Bhatt</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600105"><gtr:id>457771D7-E048-40EC-A363-EADBF2B9E093</gtr:id><gtr:title>Mycolic acid biosynthesis and processing in Mycobacterium tuberculosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0600105</gtr:grantReference><gtr:abstractText>The tuberculosis-causing, human pathogen Mycobacterium tuberculosis (MTB) contains a lipid rich ?waxy? cell wall that forms a protective barrier against harsh environments. Mycobacterial lipids not only offer a protective cover, but are also involved in interactions with infected host cells. Furthermore, some lipid components are essential for the survival of MTB and thus the enzymes that catalyze their biosynthesis represent potential targets for antimycobacterial drugs. The proposed project aims to further our understanding about how these lipid building blocks are made by generating defined mutants of MTB in candidate genes. The mutant strains will then be tested for loss of lipid components and/or accumulation of intermediate compounds. The study also aims to assess the role of specific lipids in virulence by testing these mutant strains in laboratory models of infection. The hope is that these studies will aid in our search not only for new drugs effective against tuberculosis, but also a better vaccine.</gtr:abstractText><gtr:technicalSummary>Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis, produces long chain alpha-alkyl, beta-hydroxy fatty acids, termed mycolic acids, that are important constutuents of its distinct, lipid rich cell envelope. Mycolic acids, synthesized by a fatty acid synthase II (FASII) complex, are found either esterified to the peptidoglycan-linked arabinogalactan complex, or present as a part of the interspersed glycolipid, trehalose dimycolate (TDM). The broad aim of the proposed project is to use null mutants, generated by allelic exchange, to help understand mycolic acid biosynthesis and processing pathways in mycobacteria, and outline their role in MTB pathogenesis. More specifically the objectives of the proposed study are:
1) Identify the genes encoding enzymes involved in a key desaturation step in mycolic acid synthesis.
2) Study the effects of mycolic acid chain length shortening in a MTB kasB deletion mutant on the virulence and immunomodulatory properties of MTB.
3) Delineate processes involved in post FASII intracellular processing of mycolic acids and their transport outside the cell.
4) Assess the importance of the above mentioned biosynthetic steps in pathogenesis by checking mutant or conditional mutant strains for surivival in macrophages and immunocompetent mice, and by purifying intermediates from these strains and testing their immunomodulatory properties in macrophages.

This study is an exercise in functional genomics, making use of information gained from the genome sequence of MTB to study mycolic acid metabolism. I plan to take a multidisclipinary approach encompassing bacterial genetics, biochemistry, chemical analysis and immunology to fulfil the objectives stated above. First, a highly efficient allelic exchange method termed Specialized Transduction will be used to generate deletion mutants in MTB, M. bovis BCG and the fast growing M. smegmatis. Next, the mutants will be thoroughly characterised using analytical techniques including TLC and HPLC. Accumulated intermediates will be purified and structural analysis will be done using Mass Spectropscopy and NMR. Finally, to assess the role of individual genes in pathogenesis, mutant strains will be tested for surivival in mice follwing aerosol infection. In parallel, purified mycolates and TDM from mutant strains will be tested for immunomodulatory properties in macrophages using microarrays and ELISA.</gtr:technicalSummary><gtr:fund><gtr:end>2011-11-19</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-11-20</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>676251</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Minho</gtr:collaboratingOrganisation><gtr:country>Portugal, Portuguese Republic</gtr:country><gtr:description>Role of lipids in Mycobacterium tuberculosis-host interactions</gtr:description><gtr:id>6E6C3CB7-DE41-4E5C-AE88-CAEB2AD8A60A</gtr:id><gtr:impact>Successful application for a Royal Society International Exchanges Award.</gtr:impact><gtr:outcomeId>56dd52fb020348.93048491-1</gtr:outcomeId><gtr:partnerContribution>Dr.Bhatt has the opportunity to expand his projects to include TB-immunology via the specialised expertise of Dr.Saraiva.</gtr:partnerContribution><gtr:piContribution>Dr.Saraiva will benefit from access to mutants from Dr.Bhatt's lab and to lipid extraction methodologies. In the future the project could expand to include animal models of infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Indian Institute of Science, Bangalore</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:department>Division of Biological Sciences</gtr:department><gtr:description>Lipids as a biomarker for TB</gtr:description><gtr:id>2B45E6E5-72BA-40D3-97CE-C917723B69D3</gtr:id><gtr:impact>Multidisclipinary collaboration which is at the halfway stage and thus no immediate outputs to report at this stage. The project is funded by the UK-India Education and Research Initiative.</gtr:impact><gtr:outcomeId>T9XinvFeYJx-1</gtr:outcomeId><gtr:partnerContribution>Expertise in Raman and infrared spectroscopy as methods for detecting lipids from mycobacteria</gtr:partnerContribution><gtr:piContribution>Training of staff and PhD students from IISc bangalore in the extraction of mycobatcerial lipids. Additionally, provision of mutant strains as controls of the development of lipids as a bio marker for detecting TB bacilli using infrared spectroscopy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>VU University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Medical Microbiology and Infection Control</gtr:department><gtr:description>Zebrafish embryo model of mycobacterial infection</gtr:description><gtr:id>A48D3970-7BC7-4106-B5B7-2E5AA0A276A1</gtr:id><gtr:impact>Two manuscripts which contain data that has resulted from this collaboration are currently being written up.</gtr:impact><gtr:outcomeId>MkDJ9kuhGgD-1</gtr:outcomeId><gtr:partnerContribution>Dr.A. van derSaar is an expert in zebrafish models of bacterial infection and tests mutants of Mycobacterium marinum generated in my group for attenuation in the zebrafish embryo model of infection.</gtr:partnerContribution><gtr:piContribution>Generated Mycobacterium marinum strains defective in cell wall lipids</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Immunology NII</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>Effect of phosphorylation on activities of mycolic acid synthesising enzymes</gtr:description><gtr:id>B4B11169-4E72-43B4-BB13-480C2BD7CF41</gtr:id><gtr:impact>Recent joint publication in the Journal of Biochemistry (PMID 20864541)</gtr:impact><gtr:outcomeId>di9ADXDeeup-1</gtr:outcomeId><gtr:partnerContribution>Dr.V. Nandicoori is an expert on protein phosphorylation and as part of an ongoing collaboration evaluates the effect of phosphorylation on activities of mycolate biosynthesis candidates identified in our studies.</gtr:partnerContribution><gtr:piContribution>Provide access to mutant strains defective in mycolate biosynthesis, to test hypothesis regarding the potential role of phosphorylation in regulating mycolate biosynthesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Osaka City University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>Graduate School of Medicine</gtr:department><gtr:description>A mouse-injection model to study effects of purified mycobacterial lipids</gtr:description><gtr:id>51D3D996-FD6C-4BE0-BA1A-4265AEB5E7D9</gtr:id><gtr:impact>This collaborative work will form part of data that is currently being written up for publication.</gtr:impact><gtr:outcomeId>1066D6C8B58-1</gtr:outcomeId><gtr:partnerContribution>This collaboration with Dr.Nagatoshi Fujiwara has allowed us to assess the immunomodulatory potential purified mycobacterial lipids, specifically trehalose dimycolate, in a murine-injection model.</gtr:partnerContribution><gtr:piContribution>We have supplied mycobacterial glycolipids from wild type and mutant strains to be tested in the mouse-injection model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Indian Institute of Science, Bangalore</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:department>Department of Molecular Reproduction, Development and Genetics (MRDG)</gtr:department><gtr:description>cAMP metabolism and its link to the mycobacterial cell wall</gtr:description><gtr:id>66D00CFB-B7C6-4661-8357-34B69AD211FB</gtr:id><gtr:impact>Successful funding for this pcollaboration from the UK-India Education and Research Initiative for a Thematic Partnership: Novel Approaches to Tackling Tuberculosis.</gtr:impact><gtr:outcomeId>H69X7hnFcNo-1</gtr:outcomeId><gtr:partnerContribution>Access to mutant strains.</gtr:partnerContribution><gtr:piContribution>Initiated a new collaboration with Prof.Sandhya Visweswariah, IISc Banglaore, Inida in the area of linking central metabolism to the biochemistry of the cell wall. My research team contributed to the generation of knkout strains and the biochemical analysis of mutant strains.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>British Science Festival 2010</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>43E255AB-25A6-41A4-A0D3-7A2542ADBA37</gtr:id><gtr:impact>I organised an 'open access' one day symposium titled 'Tackling Tuberculosis: From the laboratory to your GP', as part of the British Science Festival held in Sept 2010 in Birmingham.

The symposium provided a common forum for scientists, clinicians and industry to present their work and discuss approaches to be taken to fight the global menace of TB.</gtr:impact><gtr:outcomeId>h6qwNJPbKNW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>487606</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant (Co-applicant)</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>70DCC72F-3AE0-4C4C-BF68-B8A22BD75C58</gtr:id><gtr:outcomeId>E7j1CxwE2oV0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical Research Foundation</gtr:department><gtr:description>Medical Research Foundation Equipment Grant</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E56C24C1-4635-4DC1-9638-F09E37FA3CCC</gtr:id><gtr:outcomeId>5458f814bec6b8.63938341</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK-India Education and Research Initiative (UKIERI)</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:id>BB8022F1-F853-45E3-B8BC-126790BD8FB8</gtr:id><gtr:outcomeId>aNV3T3EZNSn</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1440</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Vacation Studentship</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Society of General Microbiology</gtr:fundingOrg><gtr:id>D41CB2A0-BCC8-4D04-9D5A-B1C9AD43E95B</gtr:id><gtr:outcomeId>aWTxmecYiZ1</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>495902</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant (Co-applicant)</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>586E83CC-1C04-4DFF-AED1-856843F2AB91</gtr:id><gtr:outcomeId>ZSGPTbu4izn0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Internatinal Exchanges</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>BD2DEA05-CED0-4142-BAC5-9A01867C51AA</gtr:id><gtr:outcomeId>5458f87313b0b3.62197207</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>452605</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC New Investigator Grant</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D4267127-10F0-4ED7-9C82-A90E600CB7CC</gtr:id><gtr:outcomeId>Hp6VF4QSyMn</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Conditional mutant of a mycobacterial strain higlighting the essentiality of a lipid transporter for viability (and thus its potential as a drug target)</gtr:description><gtr:id>0C5C2A86-C1DB-4992-A104-A39CD09CB612</gtr:id><gtr:impact>In parallel with others we have for the first time identified the gene responsible for encoding the transporter for mycolic acids, key components of the mycobacterial cell wall responsioble for both virulence and cell viobility.</gtr:impact><gtr:outcomeId>mFJ1S6xStjm</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Conditional M. smegmatis mmpL mutant strain</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have recently generated a mutant Mycobacterium smegmatis that is unable to make mature mycolic acids, key components of the cell wall of mycobacteria like Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). The mutant accumulates precursors instead and is more sensitive to antibiotics. We are currently extending these studies to M. tuberculosis where we expect to see an effect on virulence</gtr:description><gtr:id>D85F6C54-37A2-48AC-A897-BD4C33ACF5B1</gtr:id><gtr:impact>Generation of an attenuated M. tuberculosis strain with potential use in the development for a vaccine for TB. The affected gene product may also be developed as a secondary drug target.</gtr:impact><gtr:outcomeId>F4E37F2F324</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mycolate-less strains of mycobacteria</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C9F2BFE8-6A34-493E-A968-8FE1225BCAAF</gtr:id><gtr:title>Non-acid-fastness in Mycobacterium tuberculosis ?kasB mutant correlates with the cell envelope electron density.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56141f6fe6b75e1faff5f4992fe1874f"><gtr:id>56141f6fe6b75e1faff5f4992fe1874f</gtr:id><gtr:otherNames>Yamada H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>pm_14970_20_22516756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C302DBC-C6BD-44DD-8577-711EA0057925</gtr:id><gtr:title>New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections.</gtr:title><gtr:parentPublicationTitle>Expert review of vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00433794477b00a4a58f790cc6072c69"><gtr:id>00433794477b00a4a58f790cc6072c69</gtr:id><gtr:otherNames>Dover LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1476-0584</gtr:issn><gtr:outcomeId>EC949C65C8D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F6019AF-3338-4306-90E6-2DC8C8B64619</gtr:id><gtr:title>MKAN27435 is required for the biosynthesis of higher subclasses of lipooligosaccharides in Mycobacterium kansasii.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5abf19a4d19ced71104dbc33c7cfc9bb"><gtr:id>5abf19a4d19ced71104dbc33c7cfc9bb</gtr:id><gtr:otherNames>Nataraj V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56dd5111272518.78257841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A99BE7DE-60BF-4138-A9EC-7CA0D907B140</gtr:id><gtr:title>Loss of a mycobacterial gene encoding a reductase leads to an altered cell wall containing beta-oxo-mycolic acid analogs and accumulation of ketones.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab35eba433db30e03147923f9c6b63d"><gtr:id>fab35eba433db30e03147923f9c6b63d</gtr:id><gtr:otherNames>Bhatt A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>FF85BE9E6B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C188146A-316A-4306-8046-19BF3D21ACA6</gtr:id><gtr:title>Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab35eba433db30e03147923f9c6b63d"><gtr:id>fab35eba433db30e03147923f9c6b63d</gtr:id><gtr:otherNames>Bhatt A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>AEC704E6E8F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B18F432-800E-47F7-B1C3-F6919BAECA2E</gtr:id><gtr:title>Ancient mycobacterial lipids: Key reference biomarkers in charting the evolution of tuberculosis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c51acdaa1386ce06c743df1c3ddce41"><gtr:id>7c51acdaa1386ce06c743df1c3ddce41</gtr:id><gtr:otherNames>Minnikin DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>56dd5110bf37c8.30305973</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78064CD7-91A8-44B1-B536-B062B17E3538</gtr:id><gtr:title>Platensimycin activity against mycobacterial beta-ketoacyl-ACP synthases.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/962767f96f457e07606b64e91d28b5fd"><gtr:id>962767f96f457e07606b64e91d28b5fd</gtr:id><gtr:otherNames>Brown AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>3051A3C6C4E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B2A6746-DCC2-4475-8575-38479CC17609</gtr:id><gtr:title>Phosphorylation of enoyl-acyl carrier protein reductase InhA impacts mycobacterial growth and survival.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f866ece9ee13c82de8b8a205ee4b33b2"><gtr:id>f866ece9ee13c82de8b8a205ee4b33b2</gtr:id><gtr:otherNames>Khan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>ei5qYV411LW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A76F053B-B97F-48D8-98FA-4224C4A40CE1</gtr:id><gtr:title>Disruption of the serine/threonine protein kinase H affects phthiocerol dimycocerosates synthesis in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6d666cf487ea5850394274a2a840a19"><gtr:id>c6d666cf487ea5850394274a2a840a19</gtr:id><gtr:otherNames>G?mez-Velasco A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>pm_14970_20_23412844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8609C0E4-99CA-4E4F-A55C-0382E4DB261B</gtr:id><gtr:title>Tuberculosis: a balanced diet of lipids and carbohydrates.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/749291bc8fb7017a50d46025281050b0"><gtr:id>749291bc8fb7017a50d46025281050b0</gtr:id><gtr:otherNames>Bhowruth V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>A6FD0AE2435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6054483F-4A7E-4822-82D3-B2867886A1F2</gtr:id><gtr:title>Unexpected link between lipooligosaccharide biosynthesis and surface protein release in Mycobacterium marinum.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4629236402c2dbd1bcad1381efacde4d"><gtr:id>4629236402c2dbd1bcad1381efacde4d</gtr:id><gtr:otherNames>van der Woude AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14970_20_22505711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8667CD44-87FC-4226-87C4-166A539E23CC</gtr:id><gtr:title>Ppm1-encoded polyprenyl monophosphomannose synthase activity is essential for lipoglycan synthesis and survival in mycobacteria.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec618b82eccbef9ee2dab3ff41115627"><gtr:id>ec618b82eccbef9ee2dab3ff41115627</gtr:id><gtr:otherNames>Rana AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14970_20_23118955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA3B1C4C-F514-443D-B2DC-3A5717250A6D</gtr:id><gtr:title>Identification of a glycosyltransferase from Mycobacterium marinum involved in addition of a caryophyllose moiety in lipooligosaccharides.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0efde154948da31d981e80f575a9d27f"><gtr:id>0efde154948da31d981e80f575a9d27f</gtr:id><gtr:otherNames>Sarkar D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>HuetVwqpSAk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A632CC7E-BF19-49BA-95CF-51B7C4232C31</gtr:id><gtr:title>Identification of a Desaturase Involved in Mycolic Acid Biosynthesis in Mycobacterium smegmatis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62669b53e98481724294af0f7a2ae396"><gtr:id>62669b53e98481724294af0f7a2ae396</gtr:id><gtr:otherNames>Singh A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c6a41b6f5b78.98922256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECFC16C4-0429-41C5-B326-62E430184D8B</gtr:id><gtr:title>Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/962767f96f457e07606b64e91d28b5fd"><gtr:id>962767f96f457e07606b64e91d28b5fd</gtr:id><gtr:otherNames>Brown AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>7449DDDC696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E14B38D3-EA94-4A94-99C9-68D368182B4D</gtr:id><gtr:title>THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria.</gtr:title><gtr:parentPublicationTitle>Nature microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/358ab537e0144d3dd636ea6d4483d9fe"><gtr:id>358ab537e0144d3dd636ea6d4483d9fe</gtr:id><gtr:otherNames>Cox JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-5276</gtr:issn><gtr:outcomeId>58c6a44fafc983.06989086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CBDEA0A-18A1-4B78-A965-4E490D5F6DC8</gtr:id><gtr:title>Identification of a novel alpha(1--&amp;gt;6) mannopyranosyltransferase MptB from Corynebacterium glutamicum by deletion of a conserved gene, NCgl1505, affords a lipomannan- and lipoarabinomannan-deficient mutant.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1764466a9db2af8c2be90c94ee57fb4e"><gtr:id>1764466a9db2af8c2be90c94ee57fb4e</gtr:id><gtr:otherNames>Mishra AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>E6AD1F7453E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B07C22F9-4BA4-4BD1-95AF-17FDF26FD98B</gtr:id><gtr:title>Identification of the dehydratase component of the mycobacterial mycolic acid-synthesizing fatty acid synthase-II complex.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/962767f96f457e07606b64e91d28b5fd"><gtr:id>962767f96f457e07606b64e91d28b5fd</gtr:id><gtr:otherNames>Brown AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>8D7F2D5603F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6AC2BF6-D700-4CD7-B8CD-41222D95D8FA</gtr:id><gtr:title>Defects in glycopeptidolipid biosynthesis confer phage I3 resistance in Mycobacterium smegmatis.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/153374a71b6b5db7df216b1c08d64f74"><gtr:id>153374a71b6b5db7df216b1c08d64f74</gtr:id><gtr:otherNames>Chen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>6EADE7B5015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4593B225-5F40-4DE8-9AA9-D4FAE99E491E</gtr:id><gtr:title>MmpL genes are associated with mycolic acid metabolism in mycobacteria and corynebacteria.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e16fa20e2920f7e6600c3cfab71a0caa"><gtr:id>e16fa20e2920f7e6600c3cfab71a0caa</gtr:id><gtr:otherNames>Varela C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>pm_14970_20_22520756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37F4DDE9-1D4B-4353-BACD-A776900A2963</gtr:id><gtr:title>Mycolic acids: deciphering and targeting the Achilles' heel of the tubercle bacillus.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5abf19a4d19ced71104dbc33c7cfc9bb"><gtr:id>5abf19a4d19ced71104dbc33c7cfc9bb</gtr:id><gtr:otherNames>Nataraj V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>56dd51114e4f25.16855761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C100D779-D906-4840-809A-DC9F655EDE52</gtr:id><gtr:title>The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab35eba433db30e03147923f9c6b63d"><gtr:id>fab35eba433db30e03147923f9c6b63d</gtr:id><gtr:otherNames>Bhatt A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>BBD9C43AD27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6D0574C-DBCF-4DDC-87F4-23A516AF7228</gtr:id><gtr:title>CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99d316b5b6f301dcfb6682ca961245f3"><gtr:id>99d316b5b6f301dcfb6682ca961245f3</gtr:id><gtr:otherNames>Ly D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>pm_14970_20_23530121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64867B14-06FB-4CEB-86AD-F183B489F28B</gtr:id><gtr:title>The C-terminal domain of the Arabinosyltransferase Mycobacterium tuberculosis EmbC is a lectin-like carbohydrate binding module.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/938585ac20ff7a91cc730466157b3634"><gtr:id>938585ac20ff7a91cc730466157b3634</gtr:id><gtr:otherNames>Alderwick LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>o89phUFSXGf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D21EE049-C4DC-44AA-9208-31975405500E</gtr:id><gtr:title>Characterization of a beta-hydroxybutyryl-CoA dehydrogenase from Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bca96292966fdd05e191aaac826d4e92"><gtr:id>bca96292966fdd05e191aaac826d4e92</gtr:id><gtr:otherNames>Taylor RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>dTBmDnTFKgX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>593DC6BA-805B-4432-B6B2-B8BEF62F5A78</gtr:id><gtr:title>Biosynthesis of mycobacterial arabinogalactan: identification of a novel alpha(1--&amp;gt;3) arabinofuranosyltransferase.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cc553143c062c43864af4ca99cc7410"><gtr:id>2cc553143c062c43864af4ca99cc7410</gtr:id><gtr:otherNames>Birch HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>6A9DB3742F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F690318-28DC-43F1-ADD5-E64BFD7104F4</gtr:id><gtr:title>A truncated lipoglycan from mycobacteria with altered immunological properties.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cc553143c062c43864af4ca99cc7410"><gtr:id>2cc553143c062c43864af4ca99cc7410</gtr:id><gtr:otherNames>Birch HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>Y1PvUwMcE3T</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600105</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>